Investigators from BC Cancer – Prince George (Centre for the North) are co-authors on three international collaborative publications featured in the same issue of The Lancet Oncology. These papers reflect the centre’s engagement in global research collaborations that shape how cancer care is studied, reported, and delivered.
Researchers at BC Cancer Research Institute, led by Dr. Bernie Eigl, director of the Provincial Clinical Trials Office, and Dr. Alex Wyatt, senior scientist and scientific director of the Cancer Genetics and Genomics Laboratory, examined whether a blood test that analyzes cancer-derived DNA found in the blood, called circulating tumour DNA (ctDNA), could help identify more patients with metastatic urothelial carcinoma – an aggressive form of bladder cancer – who are eligible for FGFR-targeted therapy.
Three projects led by BC Cancer researchers and focused on advancing cancer care have been funded through the inaugural UBC AI and Health Network Fellows Program, which supports researchers harnessing artificial intelligence (AI) to transform health research and improve patient care across BC.
Dr. Kim Chi, medical oncologist and clinician-scientist with BC Cancer, has been named a highly cited researcher in 2025 by Clarivate, a global organization that analyzes academic publications, citations and research impact.
“This recognition reflects my career-long commitment to improving care for people with prostate cancer,” says Dr. Kim Chi, medical oncologist, BC Cancer. “Our research has always been driven by the needs of patients, and this honour highlights the collective efforts of our collaborators, co-investigators and dedicated staff who make this work possible.”
Congratulations to the recipients of the BC Cancer Foundation (BCCF) Rising Stars Graduate Awards competition!
This year’s awardees are:
BC Cancer’s 2025 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.
2025 Emerging Multidisciplinary Research Programs Recipients:
Each year, the UBC Faculty of Medicine (FoM) recognizes faculty members who have made exceptional contributions in the areas of education, research and/or service, and who are dedicated to advancing both the Faculty’s values and vision of transforming health for everyone.
Two BC Cancer researchers are recipients of the 2025 UBC FoM Distinguished Achievement Awards in the following categories:
A new BC Cancer project has been shown to expedite the triaging of breast cancers and accelerate the initiation of treatment.
The CAN-TRI-NLP, or a “CANcer TRIage system to expedite care with Natural Language Processing” project, was funded through the Ministry of Health's Innovation Pathway Program to explore a new expedited breast cancer triage system for faster initiation of appropriate treatment, chemotherapy or surgery.
The groundbreaking seventeen-year study involved researchers from UBC’s Faculty of Medicine as well as researchers at 55 sites across Canada, Australia and the United Kingdom.
British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers has been launched by Vancouver Coastal Health in collaboration with BC Cancer physicians and scientists. Located at Vancouver General Hospital (VGH), the new Hematology Research Unit will deliver revolutionary therapies — including first-in-human treatments such as advanced immunotherapies like CAR T-cell therapy — to patients with relapsed or treatment-resistant hematological diseases.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.